Announcing our Champion Corporate Partner: Amgen

MRF Corporate Partners are our valued corporate supporters who share our passion for providing hope, help, and healing for the 39 million American migraine sufferers and our mission of funding innovative research.

The support of these companies enables us to fund high-impact research that will improve the lives of sufferers. We’re pleased to announce Amgen as our Champion Corporate Partner. We’re extremely honored to partner with Amgen, and proud of their support of our critical role in funding research into the causes and better treatments of migraine. Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit